H+-ATPase B-subunit Dysfunction and Calcium Nephrolithiasis
H+-ATPase B-subunit Dysfunction and Calcium Nephrolithiasis
批准号:
7930519
负责人:
Orson W Moe
金额:
$39.25万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-15 至 2011-08-31
关键词:
ATP HydrolysisATP phosphohydrolaseAddressAldehyde-LyasesAllelesAnionsBindingBiochemicalBiochemistryBiologyCalciumCalcium OxalateCalculiCandidate Disease GeneCarbonic Anhydrase IICarrier StateCatalogingCatalogsCellsCellular biologyChemicalsChemistryClinicalClinical DataCodeComplexCouplingDataDatabasesDefectDiagnosisDiseaseDistal renal tubular acidosis Type 1FaceFamily memberFoundationsFrequenciesFunctional disorderGene FrequencyGeneral PopulationGenesGeneticGenetic VariationGenotypeGray unit of radiation doseHeterozygoteHumanHydrolysisIn VitroIndividualInheritance PatternsInheritedInpatientsKidneyKidney CalculiKidney DiseasesLaboratory StudyLow PrevalenceMammalian CellMetabolicMolecularMutationNephrolithiasisOxalatesPatientsPersonsPhenotypePhysiologyPlasmaPoint MutationPolygenic TraitsPopulationPredispositionProcessProtein BiochemistryProteinsProton PumpProton-Translocating ATPasesPumpRiskRisk FactorsStructureSystemTestingUrineVariantWorkYeastsbasecalcium phosphatecohortgenetic varianthigh riskhuman datahypercalciuriainhibitor/antagonistmedical attentionmutantpopulation basedpublic health relevancereconstitutionresearch studyvacuolar H+-ATPase
中文摘要
描述(由申请人提供):肾结石的遗传成分是一个复杂的多基因特征,这是一个巨大的挑战。对肾结石单基因病因的研究在揭示肾结石的遗传成分方面提供了最丰富的信息。钙质结石常见于先天性远端肾小管酸中毒患者:dRTA;但sd RcoTnAs被认为是钙结石的一个非常罕见的原因,因为这种疾病的患病率很低。先天性dRTA是一种由空泡VPa突变引起的肾脏酸化疾病;se-A T:B1或a4亚基;阴离子交换器1或碳酸酐酶II。本研究的重点是v - atp酶的B1亚基。杂合载体状态通常被认为是沉默的。突变B1亚基引起泵功能障碍的机制尚不清楚。在本提案中,我们将检验3个假设:1 . B1杂合突变在成石群体中并不罕见。2。杂合性的负担并不是无声的,而是磷酸钙或草酸盐肾病的倾向或痛苦。3。突变B1亚基通过多种机制引起泵功能障碍,如泵组装缺陷,ATP结合/水解受损以及与HE易位的紊乱耦合。我们将用3个目标来检验这些假设:基于人群的研究:确定结石形成人群和非结石形成人群中B1所有碱基变化的等位基因频率,并收集这些个体的相应临床资料。2. 住院人体研究:对选定的B1杂合个体进行详细的代谢和物理化学研究,以表征其表型。3. 台式研究:利用细胞生物学和生物化学定义各种突变B1亚基如何引起HE泵功能障碍的机制。这不是对经典dRTA的研究。相反,我们可能能够证明单基因易感性在一般结石形成人群中并不罕见,许多结石形成者可能携带B1突变,使他们易患钙结石。这可能为一般结石形成人群中的其他单基因易感性设定先例。这些研究也将显著促进对v - atp酶生物学的理解。这些自然点突变及其同源功能障碍模式将为B1蛋白的生物学提供有价值的结构-功能信息。公共卫生相关性:每个人一生中有10-20%的机会得肾结石。如果一个人有家庭成员患有肾结石,那么这个人患肾结石的风险就更高。这个过程可能涉及许多基因,但在某些情况下,单个基因可能使一个人有患肾结石的风险,例如在远端肾小管酸中毒(简称dRTA)的情况下。大多数接受dRTA治疗的患者会患上钙性肾结石,但大多数患有钙性肾结石的患者不接受dRTA治疗。这个建议探讨了一些新的想法。根据我们去年的工作,我们认为一种较温和的dRTA形式,即一个人继承一个而不是两个有缺陷的基因,称为“杂合状态”,可能在钙性肾结石患者中相当普遍。该基因编码一种名为“B1”的蛋白质,这种蛋白质在异常状态下会改变尿液中的成分,导致肾结石的形成。我们将使用人口和实验室研究来回答三个问题。1. 在钙质肾结石患者中,杂合状态的异常B1有多常见?2. 如果一个人携带异常的B1拷贝(杂合状态),那么尿液中的异常究竟是什么使这个人易患肾结石?3. 异常的B1是如何改变尿液的成分从而形成肾结石的?这些问题的答案有助于我们了解肾结石的遗传成分,以及单一蛋白质(如B1)的异常如何以不利的方式改变我们的尿液成分,从而使我们能够更好地预测、诊断和治疗肾结石。
英文摘要
DESCRIPTION (provided by applicant): The hereditary component of nephrolithiasis is a complex polygenic trait which is a formidable challenge to unravel. The study of monogenic causes of nephrolithiasis has been most informative in uncovering genetic components of nephrolithiasis. Calcareous stones are common in patients with congenital distal renal tubular acidosis :dRTA; but sd RcoTnAs idered a very rare cause of calcium stones due to the low prevalence of the disease. Congenital dRTA is a disease of renal acidification caused by mutations in either the vacuolar :VPa;se-A T :B1 or a4 subunit;, anion exchanger-1, or carbonic anhydrase II. This proposal focuses on the B1 subunit of the V-ATPase. The heterozygous carrier state is universaly believed to be silent. The mechanisms by which a mutant B1 subunit cause pump dysfunction is not well understood. We will test 3 hypotheses in this proposal: I. Heterozygous mutations of B1 are not rare in the stone forming population. II. The burden of heterozygosity is not silent but confers propensity for or affliction by calcium phosphate or oxalate nephrolithiasis. III. Mutant B1 subunits cause pump dysfunction by multiple mechanisms such as defective pump assembly, impaired ATP binding/hydrolysis, and deranged coupling to HE translocation. We will test these hypotheses with 3 Aims: 1. Population-based studies: Define the allele frequency of all base changes in B1 in the stone forming and non-stone forming population and collect the corresponding clinical data of these individuals. 2. Inpatient human studies: Perform detailed metabolic and physicochemical studies of selected individuals heterozygous for B1 to characterize their phenotype. 3. Bench studies: Define the mechanisms of how various mutant B1 subunits cause HE pump dysfunction using cell biology and biochemistry. This is not a study of classical dRTA. Instead we may be able to prove that monogenic predisposition is actually not rare in the general stone-forming population and many stone formers may harbor B1 mutations that predispose them to calcium stones. This may set precedence, for other monogenic predispositions in the general stone forming population. These studies will also significantly advance the understanding of V-ATPase biology. These natural point mutations and their cognate mode of dysfunction will provide valuable structure-function information on the biology of the B1 protein. PUBLIC HEALTH RELEVANCE: Each human has a 10-20% chance of getting a kidney stone in his or her lifetime. If a person has a family member with kidney stones, that individual has a higher risk of getting kidney stones. This process can involve many genes but there are circumstances where single genes can put a person at risk for kidney stones such as in a condition is distal renal tubular acidosis (abbreviated as dRTA). Most patients with dRTA get calcium kidney stones, but most patients with calcium kidney stones do not have dRTA. This proposal examines some new ideas. Based on our work in the last year, we believe that a milder form of dRTA where one inherits one instead of two defective genes, termed "heterozygous state" may be quite common in the general population of calcium kidney stones formers. The gene in question codes for a protein called "B1" which in its abnormal state will change the composition in the urine resulting in kidney stone formation. We will use human population and laboratory studies to answer three questions. 1. Exactly how common are abnormal B1 in a heterozygous state in people with calcium kidney stones? 2. If one carries an abnormal copy of B1 (the heterozygous state), what exactly are the abnormalities in the urine that predispose that person to having kidney stones? 3. How does an abnormal B1 change the composition of our urine so kidney stones will form? These questions, when answered, help us understand the hereditary component of kidneys stones and how abnormalities in single proteins, such as B1, will change our urine composition in an unfavorable way allowing allow us to better predict, diagnose, and treat kidney stones.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Generation of High Impact Resources for Erythropoietin Receptor Research
-
批准号:7978595
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2010
-
负责人:Orson W Moe
-
依托单位:
Generation of High Impact Resources for Erythropoietin Receptor Research
-
批准号:8071128
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2010
-
负责人:Orson W Moe
-
依托单位:
H+-ATPase B-subunit Dysfunction and Calcium Nephrolithiasis
-
批准号:7655104
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2009
-
负责人:Orson W Moe
-
依托单位:
Pathogenesis of Uric Acid Nephrolithiasis: The Multifaceted Role of Renal Lipids
-
批准号:8818384
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2009
-
负责人:Orson W Moe
-
依托单位:
Pathogenesis of Uric Acid Nephrolithiasis: The Multifaceted Role of Renal Lipids
-
批准号:8926954
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2009
-
负责人:Orson W Moe
-
依托单位:
Pathogenesis of Uric Acid Nephrolithiasis: The Multifaceted Role of Renal Lipids
-
批准号:9103087
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2009
-
负责人:Orson W Moe
-
依托单位:
Cell Biology, Pathology, and Imaging Core
-
批准号:10170322
-
项目类别:
-
资助金额:$18.45万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
Enrichment Program
-
批准号:10170326
-
项目类别:
-
资助金额:$2.36万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
UT southwestern O'Brien Kidney Research Core Center
-
批准号:8885803
-
项目类别:
-
资助金额:$116.55万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
Physiology Core
-
批准号:10170321
-
项目类别:
-
资助金额:$26.17万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
UT Southwestern O'Brien Kidney Research Core Center
-
批准号:10170318
-
项目类别:
-
资助金额:$117.15万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
Administrative Core
-
批准号:10170319
-
项目类别:
-
资助金额:$18.49万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
UT southwestern O'Brien Kidney Research Core Center
-
批准号:9115855
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
UT southwestern O'Brien Kidney Research Core Center
-
批准号:9315434
-
项目类别:
-
资助金额:$2.89万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
UT southwestern O'Brien Kidney Research Core Center
-
批准号:8721928
-
项目类别:
-
资助金额:$116.55万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
Animal Models Core
-
批准号:10170320
-
项目类别:
-
资助金额:$19.36万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
Pilot and Feasibility Program
-
批准号:10170325
-
项目类别:
-
资助金额:$7.0万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
UT Southwestern O'Brien Kidney Research Core Center
-
批准号:9984190
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
ESTABLISHING DATABASE ON PLASMA LEVEL OF KLOTHO IN HUMANS, IN HEALTH AMP; DISEAS
-
批准号:7606350
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位:
UT southwestern O'Brien Kidney Research Core Center
-
批准号:9096655
-
项目类别:
-
资助金额:$116.55万
-
财政年份:2007
-
负责人:Orson W Moe
-
依托单位: